Cardiovascular effects of
NC-1100 (1-(3,4-dimethoxyphenyl)-2-(4-diphenylmethylpiperazinyl)
ethanol and possible modes of action were studied in dogs and guinea pigs. 1. In
pentobarbital-anesthetized dogs,
intravenous administration of
NC-1100 (0.05-1.6 mg/kg) induced a dose-dependent fall of blood pressure, a
bradycardia followed by temporal
tachycardia, a slight and transient stimulation of respiration and a prolongation of the R-R interval with slight augmentations of P, R and T waves in ECG. 2. In
pentobarbital-anesthetized dogs,
NC-1100 (2.5-80 micrograms/kg) administered to the maxillary and vertebral artery dose-dependently increased the blood flow in the respective artery. 3.
Intravenous administration of
NC-1100 (0.05-1.6 mg/kg) also exhibited dose-dependent increases of the maxillary and vertebral blood flow, though the increase in maxillary flow was a little reduced at a high dose of 1.6 mg/kg.
Intravenous administration of
NC-1100 (0.1-1.6 mg/kg) caused a slight increase in the aortic and coronary blood flow, a decrease in renal flow and a slight and transient decrease followed by an increase in femoral flow. 4. In
pentobarbital-anesthetized dogs,
NC-1100 (1 mg/kg) administered i.v. did not affect responses of blood pressure and heart rate to
norepinephrine and
isoprenaline (
isoproterenol) but slightly inhibited hypotensive responses to
acetylcholine.
NC-1100 had no effect on
hypertension elicited by carotid sinus reflex and on
bradycardia by vagus stimulation.
NC-1100 slightly inhibited the
tachycardia elicited by pre- as well as postganglionic stellate stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)